Prosensa Holding NV Company Profile (NYSE:RNA)

About Prosensa Holding NV (NYSE:RNA)

Prosensa Holding NV logoProsensa Holding N.V., formerly Prosensa Holding B.V., is a biotechnology company engaged in the discovery and development of ribonucleic acid-modulating (RNA)-modulating, therapeutics for the treatment of genetic disorders. The Company's primary focus is on rare neuromuscular and neurodegenerative disorders with a large unmet medical need, including Duchenne muscular dystrophy, myotonic dystrophy and Huntington's disease. The Company's clinical portfolio of RNA-based product candidates is focused on the treatment of Duchenne muscular dystrophy (DMD). The Company's platform technology allows the development of RNA-modulating therapeutics that either interferes with splicing (exon skipping, exon inclusion, or splice mutation correction), remove mutant RNA, or block RNA expression, for different indications.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Biotechnology & Medical Research
  • Sub-Industry: N/A
  • Symbol: NYSE:RNA
  • CUSIP: N/A
  • Web: www.prosensa.eu
Average Prices:
  • 50 Day Moving Avg: $19.00
  • 200 Day Moving Avg: $14.00
  • 52 Week Range: $4.00 - $23.00
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -19.00
  • P/E Growth: 0
Profitability:
  • Return on Equity: -72.90%
  • Return on Assets: -57.94%
Misc:
  • Average Volume: 187,002 shs.
 

Frequently Asked Questions for Prosensa Holding NV (NYSE:RNA)

What is Prosensa Holding NV's stock symbol?

Prosensa Holding NV trades on the New York Stock Exchange (NYSE) under the ticker symbol "RNA."

How were Prosensa Holding NV's earnings last quarter?

Prosensa Holding NV (NYSE:RNA) announced its earnings results on Monday, November, 17th. The company reported ($0.29) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($0.25) by $0.04. View Prosensa Holding NV's Earnings History.

Who are some of Prosensa Holding NV's key competitors?

How do I buy Prosensa Holding NV stock?

Shares of Prosensa Holding NV can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Prosensa Holding NV's stock price today?

One share of Prosensa Holding NV stock can currently be purchased for approximately $19.00.


MarketBeat Community Rating for Prosensa Holding NV (NYSE RNA)
Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  42 (Vote Outperform)
Underperform Votes:  52 (Vote Underperform)
Total Votes:  94
MarketBeat's community ratings are surveys of what our community members think about Prosensa Holding NV and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Prosensa Holding NV (NYSE:RNA) (How are Consensus Ratings Calculated?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Prosensa Holding NV (NYSE:RNA)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings

Earnings History for Prosensa Holding NV (NYSE:RNA)
Earnings by Quarter for Prosensa Holding NV (NYSE:RNA)
Earnings History by Quarter for Prosensa Holding NV (NYSE RNA)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/17/2014Q314($0.25)($0.29)$5.00 millionViewN/AView Earnings Details
8/12/2014Q214($0.36)($0.29)ViewN/AView Earnings Details
5/20/2014Q114$0.01$0.26$18.38 million$20.23 millionViewN/AView Earnings Details
3/17/2014($0.14)($0.12)$2.92 million$3.03 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Prosensa Holding NV (NYSE:RNA)
Current Year EPS Consensus Estimate: $-1 EPS
Next Year EPS Consensus Estimate: $-1 EPS

Dividends

Dividend History for Prosensa Holding NV (NYSE:RNA)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Prosensa Holding NV (NYSE:RNA)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Headline Trends for Prosensa Holding NV (NYSE:RNA)
Latest Headlines for Prosensa Holding NV (NYSE:RNA)
Source:
DateHeadline
finance.yahoo.com logoBioMarin Upgraded to Strong Buy, Is It in Your Portfolio? - Analyst Blog
finance.yahoo.com - April 29 at 4:32 PM
finance.yahoo.com logoHow bubbles are blown: Biotech edition
finance.yahoo.com - March 31 at 7:53 AM
finance.yahoo.com logoBioMarin to Raise Funds to Finance Prosensa Acquisition - Analyst Blog
finance.yahoo.com - January 22 at 6:00 PM
finance.yahoo.com logoState Of The Union Lights Up Biotech
finance.yahoo.com - January 21 at 6:25 AM
finance.yahoo.com logoBioMarin Gains on Vimizim 2014 View, Batten Disease Data - Analyst Blog
finance.yahoo.com - January 14 at 5:10 PM
finance.yahoo.com logoUS STOCKS-S&P 500 ticks up to record on central bank bets
finance.yahoo.com - November 24 at 4:49 PM
finance.yahoo.com logoUS STOCKS-Wall St up on central bank bets, deals support
finance.yahoo.com - November 24 at 3:19 PM
finance.yahoo.com logoUS STOCKS-Wall St hits new records, but telecom weighs on Dow
finance.yahoo.com - November 24 at 12:34 PM
finance.yahoo.com logoUS STOCKS-Wall St hits new records, boosted by cyclicals
finance.yahoo.com - November 24 at 11:18 AM
finance.yahoo.com logoBuying Glaxo's Biotech Stock Throwbacks Proves Profitable
finance.yahoo.com - November 24 at 10:57 AM
finance.yahoo.com logoUS STOCKS-Wall St surges to new records, boosted by cyclicals
finance.yahoo.com - November 24 at 10:04 AM
247wallst.com logoBig News for Ebola Stocks
247wallst.com - November 24 at 9:15 AM
finance.yahoo.com logoUS STOCKS-Futures point to higher open on merger activity
finance.yahoo.com - November 24 at 8:52 AM
finance.yahoo.com logoUS STOCKS-Futures rise, boosted by merger activity
finance.yahoo.com - November 24 at 8:14 AM
finance.yahoo.com logoBioMarin to buy Prosensa in $840 mln deal
finance.yahoo.com - November 24 at 6:24 AM

Social

Chart

Prosensa Holding NV (RNA) Chart for Saturday, September, 23, 2017

This page was last updated on 9/23/2017 by MarketBeat.com Staff